EUVIMEDScopri EUVIMED
Übersichtsarbeit

Molecular mechanisms of i Chlamydia trachomatis i resistance to antimicrobial drugs

Tomislav Mestrovic, Suncanica Ljubin-Sternak

Frontiers in Bioscience · 2018 · 23 (2) · 656-670

DOI: 10.2741/4611 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience, 2018. Written by Tomislav Mestrovic and 1 co-authors. Institution: Clinical Microbiology and Parasitology Unit, Polyclinic "Dr. Zora Profozic", Bosutska 19, 10 000 Zagreb, Croatia, and Department of Biomedical Scienc…. Cited 53 times so far (Crossref).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Chlamydia trachomatis (C. trachomatis) is a leading cause of bacterial sexually transmitted infections in developed and undeveloped countries, and therefore a global public health issue. In an era of increasing bacterial resistance to antibiotics, resistance has been an exceedingly rare phenomenon in C. trachomatis; however, clinical treatment failures attributed to multidrug-resistant C. trachomatis strains have been described on several occasions. Cell culture systems using McCoy cells and subsequent immunofluorescent staining are still the most common methodology used for antimicrobial susceptibility testing, but the presence of resistance markers should be appraised by further genetic analysis. Azithromycin resistance of C. trachomatis is often a result of the mutations in the peptidyl transferase region of 23S rRNA genes, tetracycline resistance is usually linked to the presence of foreign genomic islands integrated in chlamydial chromosome, whereas a predominant mechanism of fluoroquinolone resistance is a point mutation in the gyrA quinolone-resistance-determining region. A nucleotide substitution in rpoB gene is responsible for rifampin resistance, and different mechanisms have been involved in the development of resistance to aminoglycosides, lincomycin and sulphonamide/trimethoprim combinations.

Subjects

MeSH terms (MEDLINE)

Anti-Bacterial AgentsChlamydia InfectionsChlamydia trachomatisDrug Resistance, BacterialGenes, BacterialHumansMicrobial Sensitivity TestsMutation

Substances

Anti-Bacterial Agents

Authors and institutions

  • Clinical Microbiology and Parasitology Unit, Polyclinic "Dr. Zora Profozic", Bosutska 19, 10 000 Zagreb, Croatia, and Department of Biomedical Sciences, University Centre Varazdin, University North, 104. brigade 3, 42 0…
  • Clinical Microbiology Department, Teaching Institute of Public Health "Dr Andrija Stampar", Mirogojska cesta 16, 10 000 Zagreb, Croatia, and Medical Microbiology Department, School of Medicine, University of Zagreb, Sal…

Cite

APA

Mestrovic, T., & Ljubin-Sternak, S. (2018). Molecular mechanisms of i Chlamydia trachomatis i resistance to antimicrobial drugs. Frontiers in Bioscience, 23(2), 656-670. https://doi.org/10.2741/4611

Vancouver

Mestrovic T, Ljubin-Sternak S. Molecular mechanisms of i Chlamydia trachomatis i resistance to antimicrobial drugs. Frontiers in Bioscience. 2018;23(2):656-670. doi:10.2741/4611

BibTeX
@article{Mestrovic2018,
  author = {Mestrovic, Tomislav and Ljubin-Sternak, Suncanica},
  title = {Molecular mechanisms of i Chlamydia trachomatis i resistance to antimicrobial drugs},
  journal = {Frontiers in Bioscience},
  year = {2018},
  volume = {23},
  number = {2},
  pages = {656--670},
  doi = {10.2741/4611}
}
Start for free →